ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2871

Break of Anergy in Human Autoreactive B Cells By T Helper Signals Restores B Cell Receptor Signaling Capacity and Is Dependent on Upregulation of CD45 Phosphatase Activity-a Possible Novel Mechanism of Breech of B Cell Tolerance in Rheumatic Diseases

Peter Szodoray1, Stephanie M. Stanford2, Nunzio Bottini2 and Britt Nakken1, 1Institute of immunology, Rikshospitalet, Oslo University Hospital, Oslo, Norway, 2Cellular Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: auto-immunity and signal transduction, B cell tolerance

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: B cell Biology and Targets in Autoimmune Disease

Session Type: Abstract Submissions (ACR)

Background/Purpose : We recently identified a human B cell population, which is naturally autoreactive and tolerized by functional anergy. This population was naïve, fully mature, negative for surface IgM and expressing only IgD BCR (BND cells: naïve, D-only). The BND cells have antibody variable region genes in germline configuration and a proportion of anergic cells exhibit natural reactivity to antinuclear antigens and dsDNA. Break of B cell tolerance leading to presence of autoantibodies in rheumatic diseases may cause the initiation and perpetuation of various autoimmune processes. The aim of this study was therefore to investigate if anergy in BND cells could be overcome by T cell mediated signals as has been reported in murine systems, and furthermore, study the molecular mechanisms underlying this process.

Methods : Untouched naive and BND human B cells from healthy blood donors were purified and cultured in the presence of T cell help (e.g. IL-4 and CD40L) followed by various functional assays such as Ca2+-flux, phospho-flow (pSyk, pLyn) and standard flow cytometry

measurements of intracellular and surface B cell markers. Finally, CD45 phosphatase activity was measured utilizing fluorescent peptide-based assay.

Results : Stimulation mimicking T cell help broke anergy and forced BND cells to fully respond to antigenic stimulation by restoring normal signaling through the BCR. This was dependent on de novo protein synthesis as opposed to direct crosstalk between the BCR, IL-4 and CD40 signaling pathways. We traced the restoration of BCR signaling from downstream signaling stages such as intracellular calcium release to phosphorylation of Syk and Lyn kinase, which is located proximal to the BCR. We observed an inability of activation of Lyn in BND cells upon BCR-stimulation, while subsequent to IL-4/CD40L treatment, the activation state of Lyn was restored. Lyn kinase activity is principally regulated by CD45 phosphatase (activating) and Csk kinase (inactivating). By inhibition studies, we identified CD45 phosphatase as a key component in the process of restoration of BCR signaling by T cell mediated signals. As a next step, we therefore investigated if T helper signals regulate CD45 expression in anergic B cells. A modest upregulation of CD45 surface expression on B

cells stimulated with T cell mimicking signals was observed. Since CD45 is a complex molecule with many possible isoforms exhibiting different levels of phosphatase activity, quantitation of CD45 phosphatase activity of B cells upon T cell stimulation was performed. These analyses showed enhanced CD45 phosphatase activity upon T cell help in BND cells as well as in naive B cells, pinpointing CD45 as a key regulator of BCR signaling thresholds mediated by T cell help.

Conclusion : Our findings reveal a novel connection between T cell help, increased CD45 phosphatase activity and BCR signaling in human primary anergic and naïve B cells, and further implies that anergic BND cells may represent the precursors of autoantibody secreting plasma cells in B cell driven autoimmune conditions. Our data provide new insight in the break of humoral immune tolerance with possible diagnostic and therapeutic implications in patients with systemic autoimmune and rheumatic diseases.


Disclosure:

P. Szodoray,
None;

S. M. Stanford,
None;

N. Bottini,
None;

B. Nakken,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/break-of-anergy-in-human-autoreactive-b-cells-by-t-helper-signals-restores-b-cell-receptor-signaling-capacity-and-is-dependent-on-upregulation-of-cd45-phosphatase-activity-a-possible-novel-mechanism-o/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology